Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line
Clinical trial NCT05372198 · UNKNOWN
Trial details
- NCT number
- NCT05372198
- Sponsor
- Hubei Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2024-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.